Avantax Advisory Services, Inc. Novo Nordisk A S Transaction History

Avantax Advisory Services, Inc.

$16 Billion
Q1 2025

A detailed history of Avantax Advisory Services, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 92,809 shares of NVO stock, worth $6.41 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

92,809

Previous 81,853 13.38%

Holding current value

$6.41 Million

Previous $7.04 Million 8.47%

% of portfolio

0.04%

Previous 0.05%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 06, 2025	BUY	$69.3 - $90.95 $759,250 - $996,448	10,956 Added 13.38%	92,809 $6.44 Million
Q4 2024 Feb 07, 2025	SELL	$85.0 - $120.04 $632,315 - $892,977	-7,439 Reduced 8.33%	81,853 $7.04 Million
Q3 2024 Nov 13, 2024	SELL	$119.07 - $145.42 $999,473 - $1.22 Million	-8,394 Reduced 8.59%	89,292 $10.6 Million
Q2 2024 Aug 09, 2024	BUY	$122.71 - $146.91 $6.88 Million - $8.23 Million	56,040 Added 134.56%	97,686 $13.9 Million
Q1 2024 May 08, 2024	BUY	$102.11 - $135.92 $660,447 - $879,130	6,468 Added 18.39%	41,646 $5.35 Million
Q4 2023 Feb 07, 2024	BUY	$87.78 - $105.45 $380,175 - $456,703	4,331 Added 14.04%	35,178 $3.64 Million
Q3 2023 Nov 07, 2023	BUY	$90.94 - $199.54 $1.7 Million - $3.72 Million	18,653 Added 152.97%	30,847 $2.81 Million
Q2 2023 Aug 11, 2023	BUY	$155.98 - $172.65 $315,547 - $349,270	2,023 Added 19.89%	12,194 $1.97 Million
Q1 2023 Apr 28, 2023	BUY	$132.34 - $159.14 $11,248 - $13,526	85 Added 0.84%	10,171 $1.62 Million
Q4 2022 Feb 13, 2023	BUY	$102.55 - $135.33 $59,171 - $78,085	577 Added 6.07%	10,086 $1.36 Million
Q3 2022 Nov 01, 2022	SELL	$95.28 - $116.93 $30,966 - $38,002	-325 Reduced 3.3%	9,509 $947,000
Q2 2022 Aug 02, 2022	SELL	$103.24 - $121.81 $106,233 - $125,342	-1,029 Reduced 9.47%	9,834 $1.1 Million
Q1 2022 Apr 27, 2022	BUY	$93.1 - $112.54 $158,549 - $191,655	1,703 Added 18.59%	10,863 $1.2 Million
Q4 2021 Jan 24, 2022	SELL	$95.88 - $117.08 $17,162 - $20,957	-179 Reduced 1.92%	9,160 $1.03 Million
Q3 2021 Oct 21, 2021	SELL	$84.42 - $106.62 $11,734 - $14,820	-139 Reduced 1.47%	9,339 $895,000
Q2 2021 Jul 29, 2021	BUY	$67.66 - $84.76 $14,411 - $18,053	213 Added 2.3%	9,478 $796,000
Q1 2021 May 13, 2021	BUY	$67.06 - $75.82 $292,851 - $331,105	4,367 Added 89.16%	9,265 $624,000
Q4 2020 Jan 22, 2021	SELL	$63.89 - $73.8 $333,378 - $385,088	-5,218 Reduced 51.58%	4,898 $342,000
Q3 2020 Oct 14, 2020	BUY	$63.69 - $70.22 $408,889 - $450,812	6,420 Added 173.7%	10,116 $702,000
Q2 2020 Aug 06, 2020	BUY	$58.54 - $67.94 $2,692 - $3,125	46 Added 1.26%	3,696 $242,000
Q1 2020 Apr 30, 2020	SELL	$49.46 - $64.78 $4,847 - $6,348	-98 Reduced 2.61%	3,650 $221,000
Q4 2019 Feb 14, 2020	BUY	$49.86 - $58.26 $186,875 - $218,358	3,748 New	3,748 $217,000

Others Institutions Holding NVO

# of Institutions

1,817

Shares Held

339M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $156B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.

Account

Avantax Advisory Services, Inc. Novo Nordisk A S Transaction History